עברית

Prof. Michael Edelstein

Professor פרופ' מן המניין
Bar-Ilan Email
michael.edelstein@biu.ac.il
Fields of Interest

public health, epidemiology, infectious diseases, digital health, health inequities, health service delivery and evaluation, infectious Diseases

Personal Website
Research field
Public Health and Epidemiology
CV

Professor Michael Edelstein is a UK-trained Public Health physician specializing in infectious disease and vaccine epidemiology. He joined the Bar-Ilan University Azrieli Faculty of Medicine, in August 2020 and is a full professor.  His major research interests focus on the equitable delivery of public health programs, harnessing digital tools (and data in particular) to improve public health, applied principally, but not exclusively, to immunization programs.

Prior to joining Bar-Ilan University, Professor Edelstein was responsible for improving vaccine coverage data and optimizing the quality and use of data to improve the national immunization program across the life-course and to reduce inequalities at PHE, England’s national public health agency. As an honorary associate professor of Public Health at London School of Hygiene and Tropical Medicine, his research focused on barriers and enablers to reducing health inequalities in vaccine programs. He was the president of the infectious diseases section of the European Public Health Association (EUPHA) between 2018 and 2021.

Professor Edelstein is also deputy editor-in-chief of the journal Epidemiology and Infection, and a fellow of the UK Faculty of Public Health. He serves on the national immunization advisory committee to the Israeli Ministry of Health, and has served on several expert groups for the World Health Organization and the European Centre for Disease Prevention and Control to support global, regional and national immunization programmes in Europe and Africa.  He has over 100 peer-reviewed publications.

He can be followed on Linkedin: Michael Edelstein | LinkedIn and is always interested in hearing from students with innovative research ideas!

Courses

Epidemiology

Implementation and evaluation of equitable public health interventions

Outbreak management

Publications

Selected recent publications:

  1. Isr J Health Policy Res. 2024 Dec 5;13(1):71. doi: 10.1186/s13584-024-00660-6. Enablers to high vaccination uptake among a disadvantaged minority population: a qualitative study of the Arab population of Israel.  Essa-Hadad J, Jansen DEMC, Vervoort JPM, Edelstein M.
  2. Vaccine. 2025 Jan 12;44:126548. doi: 10.1016/j.vaccine.2024.126548. Differences in knowledge, attitudes and intentions towards HPV vaccination among young adults from diverse socio-cultural groups in Israel: A cross-sectional study. Edelstein M, Shibli H, Bornstein J.
  3. Sci Rep. 2024 Nov 26;14(1):29291. doi: 10.1038/s41598-024-80872-7. Impact of the COVID-19 pandemic on acute cardiology and neurology services in a secondary peripheral hospital. Bernstine T, Spitzer S, Pleban R, Armon-Omer A, Ron A, Kains I, Hamudi J, Shahien R, Edelstein M.
  4. NPJ Digit Med. 2024 Jul 20;7(1):194. doi: 10.1038/s41746-024-01160-2. Estimating the household secondary attack rate and serial interval of COVID-19 using social media. Dhiman A, Yom-Tov E, Pellis L, Edelstein M, Pebody R, Hayward A, House T, Finnie T, Guzman D, Lampos V; Virus Watch Consortium; Cox IJ.
  5. J Travel Med. 2024 Aug 3;31(6):taae033. doi: 10.1093/jtm/taae033. The immune status of migrant populations in Europe and implications for vaccine-preventable disease control: a systematic review and meta-analysis. Cherri Z, Lau K, Nellums LB, Himmels J, Deal A, McGuire E, Mounier-Jack S, Norredam M, Crawshaw A, Carter J, Seedat F, Clemente NS, Bouaddi O, Friedland JS, Edelstein M, Hargreaves S.
  6. BMJ Glob Health. 2024 Oct 21;9(10):e015245. doi: 10.1136/bmjgh-2024-015245. Long Covid: a global health issue - a prospective, cohort study set in four continents. Pazukhina E, Garcia-Gallo E, Reyes LF, Kildal AB, Jassat W, Dryden M, Holter JC, Chatterjee A, Gomez K, Søraas A, Puntoni M, Latronico N, Bozza FA, Edelstein M, Gonçalves BP, Kartsonaki C, Kruglova O, Gaião S, Chow YP, Doshi Y, Duque Vallejo SI, Ibáñez-Prada ED, Fuentes YV, Hastie C, O'Hara ME, Balan V, Menkir T, Merson L, Kelly S, Citarella BW, Semple MG, Scott JT, Munblit D, Sigfrid L; ISARIC Clinical Characterisation Group and ISARIC Global Covid-19 follow up working group.
  7. Hum Vaccin Immunother. 2024 Dec 31;20(1):2292376. doi: 10.1080/21645515.2023.2292376. B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patients. Bathish Y, Tuvia N, Eshel E, Tal Lange T, Sigrid Eberhardt C, Edelstein M, Abu-Jabal K.
  8. Front Public Health. 2023 Oct 12;11:1244368. doi: 10.3389/fpubh.2023.1244368. Barriers and enablers to vaccination in the ultra-orthodox Jewish population: a systematic review. Jacobson A, Spitzer S, Gorelik Y, Edelstein M.
  9. Vaccine. 2023 Mar 31;41(14):2339-2342. doi: 10.1016/j.vaccine.2023.02.043. Epub 2023 Feb 23. Linked poliovirus incidents in the UK, USA and Israel: Silent transmission or missed warnings of vaccine inequity? Ben Kasstan , Tracey Chantler , Blima Marcus, Sandra Mounier-Jack , Vanessa Saliba , Michael Edelstein
  10. Sci Rep. 2023 Sep 22;13(1):15801. doi: 10.1038/s41598-023-43058-1. Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel. Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Beiruti Wiegler K, Abu Jabal K, Dror AA, Elsinga J, Nazzal S, Glikman D, Edelstein M.
  11. Lancet. 2023 Sep 30;402(10408):1115-1117. doi: 10.1016/S0140-6736(23)01685-9. Long COVID in low-income and middle-income countries: the hidden public health crisis. Jassat W, Reyes LF, Munblit D, Caoili J, Bozza F, Hashmi M, Edelstein M, Cohen C, Alvarez-Moreno CA, Cao B.
  12. Int J Public Health. 2023 Jun 12;68:1605970. doi: 10.3389/ijph.2023.1605970. Changes in Quality of Life Following SARS-CoV-2 Infection Among Jewish and Arab Populations in Israel: A Cross-Sectional Study. Elsinga J, Kuodi P, Shibli H, Gorelik Y, Zayyad H, Wertheim O, Abu Jabal K, Dror A, Nazzal S, Glikman D, Edelstein M.
  13. Equity of the Meningitis B vaccination programme in England, 2016-2018. Tiley KS, White JM, Andrews N, Tessier E, Edelstein M. Vaccine. 2022 Oct 6;40(42):6125-6132. doi: 10.1016/j.vaccine.2022.09.023. Epub 2022 Sep 16.
  14. Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021. Morozov NG, Dror AA, Daoud A, Eisenbach N, Kaykov E, Barhoum M, Sheleg T, Sela E, Edelstein M. Hum Vaccin Immunother. 2022 Nov 30;18(6):2112879. doi: 10.1080/21645515.2022.2112879. Epub 2022 Aug 29.
  15. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Abu Jabal K, Dror AA, Nazzal S, Glikman D, Edelstein M. NPJ Vaccines. 2022 Aug 26;7(1):101. doi: 10.1038/s41541-022-00526-5.
  16. Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020-October 2021. Edelstein M, Wiegler Beiruti K, Ben-Amram H, Bar-Zeev N, Sussan C, Asulin H, Strauss D, Bathish Y, Zarka S, Abu Jabal K. Clin Infect Dis. 2022 Aug 24;75(1):e572-e578. doi: 10.1093/cid/ciac212.
  17. Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021. Gorelik Y, Anis E, Edelstein M. Lancet Reg Health Eur. 2022 Jan;12:100234. doi: 10.1016/j.lanepe.2021.100234. Epub 2021 Oct 30.
  18. Tracking COVID-19 using online search. Lampos V, Majumder MS, Yom-Tov E, Edelstein M, Moura S, Hamada Y, Rangaka MX, McKendry RA, Cox IJ. NPJ Digit Med. 2021 Feb 8;4(1):17. doi: 10.1038/s41746-021-00384-w.

 

 

 

Last Updated Date : 22/07/2025